R Chop News Today : Breaking News, Live Updates & Top Stories | Vimarsana

young mom? >> so, when you are seeing this. >> we are like oh my gosh. someone said, could this be a poison? >> this is the kind of stuff that was used by russian kgb agents. >> who in the right mind would even think of this? >> you need to search those computers, search those phones. >> this is being done to her on purpose, she is in danger. >> this evil came into our lives. how could this be? ♪ ♪ ♪ >> welcome to dateline. birgitta uto loved to ride, and was hardwired to go the extra mile with everything that she did. then, suddenly, her health collapsed. doctors were baffled ...

Chidamide plus R-CHOP has received approval from China’s NMPA for the management of diffuse large B-cell lymphoma.

A new study has found that HLX01 (HanliKang), a rituximab biosimilar, had comparable overall survival and progression-free survival rates to the reference product (Rituxan) in patients with diffuse large B-cell lymphoma (DLBCL).

The authors say their 3D model improves on results using traditional 2-dimensional approaches.

Although ibrutinib adds to the cost of treatment, its benefits over the long term justify the cost, investigators found.